Invention Grant
- Patent Title: Apixaban formulations
- Patent Title (中): 阿哌沙班制剂
-
Application No.: US13579796Application Date: 2011-02-24
-
Publication No.: US09326945B2Publication Date: 2016-05-03
- Inventor: Jatin Patel , Charles Frost , Jingpin Jia , Chandra Vemavarapu
- Applicant: Jatin Patel , Charles Frost , Jingpin Jia , Chandra Vemavarapu
- Applicant Address: US NJ Princeton US NY New York
- Assignee: Bristol-Myers Squibb Company,Pfizer Inc.
- Current Assignee: Bristol-Myers Squibb Company,Pfizer Inc.
- Current Assignee Address: US NJ Princeton US NY New York
- Agency: Fitzpatrick, Cella, Harper & Scinto
- International Application: PCT/US2011/025994 WO 20110224
- International Announcement: WO2011/106478 WO 20110901
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K31/4545 ; A61K31/437 ; A61K31/4412
Abstract:
Compositions comprising crystalline apixaban particles having a D90 equal to or less than 89 μm, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to for the treatment and/or prophylaxis of thromboembolic disorders.
Public/Granted literature
- US20130045245A1 APIXABAN FORMULATIONS Public/Granted day:2013-02-21
Information query
